COMMUNIQUÉS West-GlobeNewswire
-
Tilray Medical Welcomes Progress in Germany’s Medical Cannabis Framework and Supports Continued Policy Development
18/08/2026 -
Asimov Announces Cell Line Development Partnership with Kaigene to Advance Multispecific Antibody for Autoimmune Disease
18/08/2026 -
BlossomHill Therapeutics Announces FDA Fast Track Designation for BH-30643, a Macrocyclic OMNI-EGFR™ Inhibitor for the Treatment of Advanced EGFR C797S-positive NSCLC
18/08/2026 -
Peak Physio Launches Subscription Education Platform Arcane Physio for International Clinician Market
18/08/2026 -
Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration
18/08/2026 -
Polomar Health Services Reports Second-Quarter Revenue of $1.53 Million and Positive Net Income
18/08/2026 -
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million
18/08/2026 -
Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP
18/08/2026 -
Vivos Inc. Achieves Two Major Operational Milestones: First IsoPet® Shipments from New U.S. Production Facility and Authorization from India’s Nuclear Regulatory Authority for International Manufacturing Center
18/08/2026 -
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors
18/08/2026 -
Transactions in connection with share buy-back program
18/08/2026 -
Smith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics
18/08/2026 -
Cloud 9 Vets calls on the CMA to add at-home pet euthanasia to the new mandatory vet price list
18/08/2026 -
Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer
18/08/2026 -
Coloplast A/S - Interim Financial Report, 9M 2025/26
18/08/2026 -
Basilea reports strong 2026 half-year results and raises full-year guidance; fosmanogepix phase 3 program on track
18/08/2026 -
InnoCare Announces Approval of Head-to-Head Registrational Phase III Trial of Mesutoclax with Azacitidine versus Venetoclax with Azacitidine in Treatment-Naive AML in China
18/08/2026 -
MemoHoney Details Supplement Facts Panel, Serving Directions and Label Information
18/08/2026 -
Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights
17/08/2026
Pages